CMS published a memo April 10 that finalized a proposal to cover MRI scans for Medicare beneficiaries with implantable cardiac devices (ICDs).

Extreme temperatures can put undo pressure on the human body—which can lead to deadly complications for those with cardiovascular and respiratory conditions. Recent research discovered cold temperatures, meaning the first to third percentile of local exposure history, have an especially significant impact on mortality and morbidity for those with cardiovascular diseases.

The epidemic of physician burnout has been well-documented, although many health systems are still struggling to foster a happier workforce. While gender-specific mechanisms for burnout have recently garnered attention, age-related differences have been less examined.

As fitness increases, risk of cardiovascular disease (CVD) may decrease regardless of genetic predisposition, according to new findings published in Circulation on April 9.

Disparities remain in the impact of cardiovascular disease (CVD) around the United States—mostly due to risk factors that can be changed, according to new research published April 11 in JAMA Cardiology.

A 34-year-old nurse at a Texas hospital has been charged with murder and accused of introducing stroke-like symptoms in seven patients.

Telemedicine has gathered momentum as a solution to improve convenience and access to healthcare. However, a careful parsing of the numbers is still necessary to determine whether telehealth is really reducing spending and providing adequate value, two physicians wrote in an opinion piece published April 10 in the Annals of Internal Medicine.

AUSTIN, Texas, April 12, 2018 — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced an additional analysis from the landmark CANVAS Program showing INVOKANA® (canagliflozin) improved renal outcomes in people with type 2 diabetes mellitus with or at high risk for cardiovascular disease.

A report issued by the Institute for Patient Access suggests commercial healthcare insurance plans, as well as Medicare, Medicaid and Medicaid managed care, denied coverage for almost 80,000 insurance claims for PCSK9 inhibitors in 2017.

To mitigate the obesity epidemic, increase workplace productivity and reduce absences, employers across the United States are engaging in employee-wide wellness programs.